Copper chelation has been shown to favor the expansion of human hematopoietic stem/progenitor cells in vitro. To further understand the effects of copper modulation on defined subsets of stem cells versus progenitor cells, we extended the studies in a mouse system. We isolated mouse hematopoietic stem cells (HSCs) or hematopoietic progenitor cells (HPCs) and cultured them with or without the copper chelator tetraethylenepentamine (TEPA) or CuCl 2 . Cytokine-stimulated HPC cultures treated with TEPA for 7 days generated about two to three times more total and erythroid colony-forming cells (CFCs) compared to control cultures. In contrast, CuCl 2 treatment decreased the CFC numbers. Similar results were seen with HSC after 14, but not 7, days of culture. Transplant studies showed that HPCs cultured for 7 days in TEPA had about twofold higher short-term erythroid repopulation potential compared to control cultures, while CuCl 2 decreased the erythroid potential of cultured HPCs compared to control cultures. HSCs cultured with TEPA for 7 days did not exhibit significantly higher repopulation potential in either leukocyte or erythrocyte lineages compared to control cultures in short-term or long-term assays. Based on JC-1 staining, the mitochondrial membrane potential of HPCs cultured with TEPA was lower relative to control cultures. Our data suggest that decreasing the cellular copper content with TEPA results in preferential expansion or maintenance of HPC that are biased for erythroid differentiation in vivo, but does not enhance the maintenance of HSC activity in culture.
INTRODUCTION
HSCs. This process is tightly regulated by the interplay of extrinsic and intrinsic molecular mechanisms in order to both sustain blood production and maintain the HSC Metal elements, such as iron (Fe), calcium (Ca), magnesium (Mg), zinc (Zn), and copper (Cu), are fundamen-compartment (28) .
In vitro studies showed that addition of Cu salts aug-tal and essential for life. Cu is a cofactor for many cellular enzymes, such as cytochrome c oxidase, superoxide mented the retinoic acid-induced differentiation of the human myeloid leukemia cell line, HL-60 (1) . Lowering dismutase, tyrosinase, peptidylglycine alpha-amidating mono-oxygenase, and lysyl oxidase (17, 43, 51) . Cu has of the cellular Cu level by the Cu chelator tetraethylenepentamine (TEPA) blocked 1,25-dihydroxyvitamin D 3 also been shown to regulate gene expression, cellular protein functions, and cell differentiation (3,9,15,23,26,29, or phorbol 12-myristate 13-acetate-induced U937 cell differentiation and this blocking was reversed by adding 38, 52) . However, excess intracellular Cu is toxic due to its role in catalyzing the generation of reactive oxygen back Cu (22) . The importance of Cu in regulating hematopoiesis is also inferred from inherited or acquired Cu species (ROS) through Fenton chemistry (31) . Specifically, Cu is essential for normal hematopoiesis in which deficiency in humans and mice. Cu deficiency due to genetic mutations or malnourishment in humans causes mature blood cells are constantly replenished from hematopoietic stem cells in the bone marrow. In adult anemia, neutropenia, and thrombocytopenia due to the arrested differentiation at the hematopoietic progenitor mammals, hematopoietic stem cells (HSCs) gradually lose their self-renewal capability and multipotency and cell level (6, 13, 14, 16, 19, 36, 44, 46, 58) . Interestingly, recent studies showed that the high-restrict to specific lineages. HSC must replicate through self-renewing cell divisions to maintain the pool of affinity copper chelator TEPA, together with early act-ing cytokines [thrombopoietin (TPO), stem cell factor within the cultured cells. We used in vitro colony-forming assays and in vivo mouse competitive repopulation (SCF), interleukin-6 (IL-6), and Flt3 ligand (FL)] can promote the expansion of both hematopoietic progenitor assays to characterize and quantify the progenitor and stem cells within the cultures. cells (HPCs) and hematopoietic stem cells (HSCs) from human cord blood-derived CD34 + cells in culture
Our results show that TEPA promotes the expansion or maintenance of progenitor cells that are mainly ery-(39,41). The expansion of HPCs was shown by in vitro colony-forming assay and FACS analysis of the expres-throid lineage biased within the HPC culture. In contrast, TEPA did not significantly promote the expansion sion of cell surface markers. The expansion of the HSCs was shown by the repopulation of nonobese diabetic/ or maintenance of HSC in culture. The effects of TEPA on HPC correlate with its effect of reducing the mito-severe combined immunodeficiency (NOD/SCID) mice with cultured cells (40, 42) . This finding has justified a chondrial membrane potential of cultured HPC. clinical trial using TEPA together with cytokines for the MATERIALS AND METHODS ex vivo expansion of human HSC/HPCs prior to trans-Mice plantation into patients (11, 42) . Although the expansion of HPCs is clearly established by both the in vitro and Mice carrying the Thy-1.1 and Ly-5.1 alleles on a in vivo assays, the expansion of HSCs in these cultures C57BL background were generated in our breeding colis less convincing. ony by mating the BKa.AK-Thy1 a /Ka and B6.SJL-Ptprc a There are still many controversies about the faithful-Pep3b/BoyJ strains and selecting for cosegregation of ness of the NOD/SCID mouse model in detection and Thy-1.1 (CD90 a ) and Ly-5.1 (CD45 a ). Breeding pairs of quantification of human HSCs (7). Because the differ-B6.Cg-Gpi1 a Hbb d H1 b /DehJ mice (18) were kindly proences of the physiological environment of mouse and vided by David Harrison (Jackson Laboratory, Bar Harhuman and the differences of the life span and proliferabor, ME, USA). We refer to these mice as B6-Hbb d . tion capacities of mouse and human hematopoietic cells, GFP transgenic mice were provided by Dr. Masaru the detection of human cells in NOD/SCID mouse bone Okabe (Osaka University, Osaka, Japan). This transmarrow 8 weeks after the transplantation does not prove genic strain was generated by pronuclear injection of the contribution from the human HSCs (20). As a result, fertilized eggs obtained from C57BL/6 matings as preit is unclear whether TEPA significantly promotes the viously described (35) and are here referred to as B6self-renewal and expansion of HSCs in vitro.
GFP. Mice carrying both GFP transgene and Hbb d allele The objective of the present study was to clarify these were generated in our breeding colony by mating B6issues by extending the observations in the mouse sys-Hbb d mice with B6-GFP mice and selected for cosegregtem, where isolation and unequivocal assays for HSC ation of GFP and Hbb d . We refer to these mice as B6and HPC are better defined. To separate mouse HSCs GFP/Hbb d . All animals were maintained in the animal from HPCs for analysis of the effect of Cu modulation resources center at the University of Utah under protoon each of these two populations, we used cell surface cols approved by the institutional animal care and use markers in combination with the mitochondrial dye rhocommittee. damine-123 to fractionate mouse bone marrow cells.
Antibodies The most primitive HSC and HPC reside in a population of bone marrow cells that does not express mature blood Monoclonal antibodies against CD2 (Rm2.2), CD3 cell surface markers (lineage negative or Lin − ) and ex-(KT3-1.1), CD5 (53-7.3), CD8 (53-6.7), CD11b (M1/ presses Sca-1 and c-Kit cell surface markers. These bone 70), Ly-6G (RB6-8C5), TER119, CD45R (B220; RA3marrow cells are commonly referred to as the LSK pop-6B2), and CD19 (1D3) were purified from media of cululation (37, 49) . We further divide the LSK population tured hybridoma cell lines. Phycoerythrin (PE)-conjuby rhodamine-123 staining. Rhodamine-123 (Rho) is a gated monoclonal antibodies to Sca-1 and CD19 were mitochondrial dye that stains cells based on their state of purchased from PharMingen (San Diego, CA, USA). activation, in which the more metabolically active cells Anti-c-kit mAb 3C11 and anti-Ly5.1 mAb A20.1 were fluoresce brightly while more quiescent cells fluoresce purified and conjugated to Alexa Fluor 647 in our labodimly (2) . Segregation of the LSK population using Rho ratory. PE-conjugated monoclonal antibodies to CD4, has demonstrated that the LSKRho low population con-CD8, B220, Mac-1, and Gr-1 were purchased from tains long-term HSC with a frequency of about 25%, eBioscience (San Diego, CA, USA) or purified and conwhile the LSKRho hi population lacks HSC but is highly jugated in our laboratory. enriched for multipotent and lineage-restricted progeni-Cytokines tor cells (32, 50) . We cultured these two populations separately with early acting cytokines (SCF, TPO, IL-6, FL)
Recombinant mouse SCF was expressed in bacteria and purified from lysates as previously described (55) . and used TEPA or CuCl 2 to modulate the Cu content Recombinant mouse FL, IL-3, GM-CSF, and IL-6 were lar Cu content of cultured cells was determined using inductively coupled plasma-atomic emission spectrome-purchased from Peprotech (Rocky Hill, NJ, USA). The peptide mimetic of TPO was synthesized as previously try (ICP-AES) (Perkin Elmer Life Sciences) as described previously (30 ized bovine serum albumen (BSA), antibiotics, L-glutamine, and 2-mercaptoethanol. Colony growth and differ-Mouse bone marrow cells were incubated in a cocktail of antibodies to CD2, CD3, CD5, CD8, CD11b, Ly-entiation were stimulated with recombinant cytokines in combination as indicated, including SCF (100 ng/ml), 6G, TER119, CD45R, and CD19. Lineage depletion was performed by two successive incubations in sheep anti-G-CSF (10 ng/ml), IL-3 (10 ng/ml), IL-6 (20 ng/ml), TPO mimetic (5 nM), and Epo (4 U/ml). After 7 days rat Ig-coupled magnetic beads (Dynal, Oslo, Norway). Lineage-negative (Lin − ) cells were incubated with 0.2 of culture, quadruplicate plates were stained using benzidine hydrochloride and scored for total colonies and µM rhodomine-123 (Molecular Probes, Eugene, OR, USA) in Hank's balanced salt solution (HBSS) contain-for colonies containing hemoglobinized erythroid lineage cells colonies based on benzidine staining. ing 5% fetal calf serum at 37°C for 20 min. After washing once, the cells were resuspended in fresh HBSS and Mouse Transplantation Assay incubated at 37°C for another 20 min to allow for efflux of the dye. After washing, the cells were stained with Radiation was delivered to B6-Hbb d or B6-GFP/Hbb d recipient mice in a split dose (2 × 6 Gy) with a 3-h inter-PE-conjugated anti-Sca-1 and AlexaFluor 647-conjugated anti-c-kit antibodies. Sorting was done using FACS val between doses, using a Shepherd Mark I 137 Cs source (JL Shepherd and Associates, Glendale, CA, USA) at Vantage or FACS Aria instruments (Becton Dickinson Immunocytometry Systems, San Jose, CA, USA). We a dose rate of 0.8 Gy/min. Cultured cells mixed with competitor BM cells were transplanted by the retro-sorted Lin − Sca-1 + c-kit + (LSK) bone marrow cells as LSKRho low and LSKRho hi populations using Rho-stained orbital route under isoflurane anesthesia (IsoSol; Vedco Inc., St. Joseph, MO, USA). Peripheral blood samples bone marrow cells to determine the placement of the Rho gates. This usually resulted in LSKRho low cells were collected from the retro-orbital sinus under isoflurane anesthesia delivered using the E-Z Anesthesia sys-comprising the lower 20% of the Rho distribution and LSKRho hi cells comprising the upper 50% of the Rho tem (Euthanex Corp., Palmer, PA, USA). Blood was collected in heparinized capillary tubes and mixed with distribution. An aliquot of each sorted cell population was taken for reanalysis to evaluate purity and cell acid citrate dextrose at a 10:1 ratio prior to determination of the complete blood count using a Serono System count.
9010 + CP hematology counter (Serono Diagnostics, Al-In Vitro Liquid Culture of HSCs and HPCs lentown, PA, USA). Samples were then mixed with an equal volume of 2% Dextran T500 (Amersham Biosci-Purified LSKRho low and LSKRho hi cells were cultured in 24-well plates at 1000 cells/ml in α-MEM medium ences, Piscataway, NJ, USA) in phosphate-buffered saline (PBS) and incubated at 37°C for 30 min. The upper supplemented with 10% fetal bovine serum (FBS) (Hyclone), 2 mM L-glutamine, 100 µM 2-mercaptoetha-layer, containing leukocytes, platelets, and residual erythrocytes, was collected for flow cytometry analysis, nol, 1% each sodium pyruvate and pen/strep stock solutions (Invitrogen Corp, Carlsbad, CA, USA), and the whereas the sedimented erythrocytes were used for Hbb analysis. following mouse recombinant cytokines: SCF at 100 ng/ ml, TPO mimetic at 5 nM, IL-6 at 10 ng/ml, and FL at Determination of Hbb Variants by HPLC 10 ng/ml. Cellular Cu content was modulated by supplementing the culture with either TEPA and/or CuCl 2 A cation exchange protocol was developed to separate and quantitate Hbb variant alleles by HPLC (48) . A (both obtained from Sigma-Aldrich, St. Louis, MO, USA) as indicated. At weekly intervals, cell cultures stock solution of 100 mM 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) (Sigma-Aldrich) was prepared by dissolv-were demi-depopulated and supplemented with fresh medium, serum, cytokines, and other components as in-ing 10 mg of DTNB in 250 µl of dimethyl sulfoxide and stored at −20°C. Erythrocytes obtained from heparinized dicated. The cultures were incubated at 37°C in a humidified atmosphere of 5% CO 2 in air. At various time blood were washed three times in dextrose-gelatin-veronal buffer and stored as packed pellets at 4°C for up to points, cells were harvested and counted by hemocytometer following staining with trypan blue. The intracellu-2 weeks prior to analysis. Samples were derivatized by 890 HUANG ET AL. alone (p = 0.003 and p = 0.0007) ( Fig. 1A) . Interestingly, Progenitor Cells in the presence of 80 µM TEPA the expansion of cell numbers was reduced relative to controls while the CFC Because previous studies using TEPA in hematopoinumbers increased significantly (p = 0.0007) ( Fig. 1A) .
etic cultures have focused on human cells, an initial
In contrast, LSKRho hi HPC cultured with 10 µM CuCl 2 dose-response experiment was performed in order to plus FBS and cytokines for 7 days produced about half determine the optimal TEPA concentration in cultures of the CFCs of control culture (p = 0.004) with a similar of mouse HSC/HPC. We assayed total cell proliferation and CFC proliferation at each of the various concentrations of TEPA (5, 10, 20, 40, and 80 µM) in the presence of SCF, TPO mimetic, IL-6, and FL over 1-3 weeks. These experiments established a dose of 40 µM TEPA as optimal for mouse HSC/HPC proliferation in culture, based on CFC analysis (data not shown). We then determined the effect of supplementing TEPA and CuCl 2 on intracellular Cu content of HPC cultures. We performed two independent measurements using inductively coupled plasma-optical emission spectrometry (ICP-OES) (30) . LSKRho hi HPCs were cultured in serum and cytokine-containing medium for 7 days. Under these conditions, ICP-OES measurements indicated that cultured cells contained 7.6-12.7 ng Cu/10 7 cells. When the Cu chelator TEPA was added to the culture at 40 µM for 7 days, the cellular Cu content decreased to 2.4-2.8 ng/10 7 cells. TEPA-treated cultures showed only modest changes in other metals (Fe 30% decrease, Zn 8% decrease), suggesting that the TEPA effect is copper specific. Addition of 10 µM CuCl 2 to the culture medium increased the cellular Cu content to 686.3-3088.5 ng/10 7 cells (Table 1 ). These results indicate that the cellular Cu content of HPC can be modulated by the addition of TEPA or CuCl 2 to the culture medium. (Fig. 3A, B ). Supplementation with 10 µM CuCl 2 increased the portion of cells with differentiated cell morphology, while adding TEPA to CuCl 2 -supplemented culture reversed the effect of Cu (Fig. 3C, D) .
Effects of TEPA and Cu Supplementation in HSC/HPC Cultures

Effects of TEPA and Cu Supplementation on In Vivo Short-Term Trilineage Repopulating Activity of Cultured HPCs
To evaluate the in vivo repopulation activity of cultured cells in the three major blood lineages, we harvested 1-week cultures of LSKRho hi HPCs and transplanted these cells together with a fixed number of competitor bone marrow cells into lethally irradiated congenic recipient mice. Cultured cells were tracked based on expression of the Ly5.1 allele on the cell surface of white blood cells and the hemoglobin-β single (Hbb s ) variant in red blood cells and lack of GFP expression on platelets (48) . Competitor bone marrow and recipient mice cells expressed the Ly5.2 allele, the hemoglobin-β diffuse (Hbb d ) variant, and GFP. This transplant model allows us to track the in vivo contribution of cul- freshly obtained competitor bone marrow cells into lethally irradiated mice and followed the relative contribuexpansion of cell numbers. TEPA at 80 µM also increased the erythroid CFC number compared to control (p = 0.04) while 40 µM had no effect on erythroid CFCs (Fig. 1A) . After 14 days of culture, LSKRh hi HPCs had decreased number of total cell numbers and CFC numbers compared to day 7 cultures, but cultures supplemented with 40 or 80 µM TEPA had much more total CFC and erythroid CFC number than cultures supplemented with CuCl 2 or control cultures (Fig. 1B) . In parallel cultures initiated with LSKRho low HSC, we observed no difference in total CFC number between cell cultures with TEPA, CuCl 2 , and control in 1 week of culture ( Fig. 2A ). Relative to control cultures, we observed an increase in erythroid CFC in cultures containing 40 µM TEPA (p = 0.0001) and a decrease in erythroid CFC in cultures containing supplementary Cu ( Fig. 2A) . After 2 weeks of culture, LSKRho low cells cultured with 40 µM TEPA generated about 30% more total CFCs compared to control cultures containing cytokines only, while treatment with 10 µM CuCl 2 decreased the total CFCs in culture compared to control (Fig. 2B) .
We examined the morphology of the cells in cultures more cells with morphological characteristics of differ-tions of cultured cells and competitor BM cells into the leukocyte, platelet, and erythrocyte lineages in the peripheral blood of recipient mice over time. LSKRho hi cells cultured with 40 µM TEPA generated about twofold higher percentage of reconstitution of the erythroid lineage compared to LSKRho hi cells cultured with cytokines alone, in spite of a lower degree of cellularity in the cultures expanded under this condition (Fig. 4A, B) .
The red blood cell count of the recipient mice was similar among the groups (data not shown). This enhancement of erythroid engraftment persisted over the time course of progenitor cell activity in the recipients, and was limited to the erythroid lineage as these cultures had about 30% of the leukocyte lineage repopulation activity of LSKRho hi cells cultured with cytokines alone. The effect of TEPA was reversed by addition of CuCl 2 into the culture medium. TEPA and Cu had no obvious effects on platelet lineage repopulation activity of cultured LSKRho hi cells (data not shown). The contribution of cultured cells to the peripheral blood of recipient mice was limited to 9 weeks posttransplantation, consistent with the absence of stem cells in the LSKRho hi population and its cultured progeny. Collectively, our results suggest that TEPA preferentially promotes the maintenance or expansion of erythroid-biased progenitor cells in cultures established from primitive progenitor cells.
Effects of TEPA and CuCl 2 Supplementation on the Short-Term and Long-Term Repopulation Capacity of Cultured HSCs
To evaluate the effects of TEPA on expansion of HSC number and function, we tested the activity of cultured LSKRho low HSC in the long-term competitive repopulation assay. The 7-day cultured cells derived from 10 3 LSKRho low BM cells were cotransplanted with 10 6 fresh competitor BM cells into lethally irradiated recipient mice. The relative contribution of cultured cells and competitor cells into peripheral blood leukocyte and had significantly less repopulation capacity in the leukodays. The total cell numbers were determined at the end of culture (A). The total cells were mixed with 10 5 whole BM cyte lineage than control cultures (p = 0.02) or cultures cells and injected intravenously into lethally irradiated mice. supplemented with 10 µM CuCl 2 (p = 0.002) (Fig. 5A) . tion potential of cultured cells under different conditions (Fig. 5B) . At 5 months posttransplantation, HSCs cultured with 40 µM TEPA showed a slight increase in the Effects of TEPA and Cu Supplementation repopulation in leukocyte and erythrocyte lineages, but on the Mitochondrial Membrane Potential this increase was not statistically significant (p = 0.38) of Cultured Progenitor Cells (Fig. 5A, C) . Based on these data, we conclude that TEPA does not significantly increase the maintenance To gain some insights into the mechanisms of TEPA's effect on LSKRho hi progenitor cells and their progenies or expansion of short-term or long-term HSCs in culture.
in culture, we measured the mitochondrial membrane potential of day 7 cultures of LSKRho hi cells. We used the cationic dye JC-1 that indicates increased mitochondrial polarization by shifting its fluorescence emission from green (525 nm) to red (575 nm). JC-1 staining of LSKRho hi bone marrow cells cultured for 7 days showed that 40 µM TEPA increased the number of cells that have relatively low mitochondrial membrane potential and decreased the number of cells that have relatively high mitochondrial membrane potential compared to control cultures containing only cytokines (Fig. 6) . The effect of TEPA on mitochondrial membrane potential of cultured cells was reversed by adding a low amount of exogenous Cu into TEPA-supplemented cultures, suggesting reduction of Cu concentration within the cell is responsible for the effect of TEPA (Fig. 6) .
DISCUSSION
Copper has long been known to be essential for normal hematopoiesis in mammals from both in vitro and in vivo studies. However, the effects of fine-tuning of intracellular copper content on the regulation of HSC/ HPCs self-renewal and differentiation are relatively unknown. Recently, some interesting findings suggested that reducing the intracellular Cu content by Cu chelation in human HSC/HPCs is beneficial for their expansion or maintenance in culture. While this finding is very intriguing and promising, it is unclear whether cop- per chelation expands or maintains the activities HSC, weeks posttransplantation, HSC cultures treated with TEPA showed a decreased leukocyte repopulation po-HPC or both, due to the difficulty of faithfully separating and measuring human stem and progenitor cell ac-tential compared control cultures. At 3-5 months posttransplantation, HSC cultures treated with TEPA showed tivities. HSC are strikingly different from HPC in that HSC can repopulate the hematopoietic system for a life-a slightly increased repopulation potential in both leukocyte and erythroid lineages, but this increase was not long period, while HPC can only function for a limited time. The in vivo repopulation potential of human HSC/ statistically significant. These results suggest that TEPA does not promote the expansion or maintenance of HSCs HPCs can be estimated using xenotransplantation models, usually using the NOD/SCID mouse as a transplant in cytokine-supplemented cultures. Interestingly, we did not see a similar effect of TEPA on short-term erythroid-recipient. The NOD/SCID mouse is a widely used model for assessing human HSC/HPCs. However, it is biased progenitors in LSKRh low HSC culture as in LSKRh hi HPC culture. This suggests that TEPA acts on a very still uncertain how well it is able to faithfully measure and quantify human HSC/HPCs, and the utility of the specific population of progenitor cells that are contained in the LSKRh hi cell population or their progenies but model in predicting human engraftment is controversial.
To better address this issue and to gain some insights not contained significantly in LSKRh low cells and their cultured progenies. Further studies are needed to iden-into the mechanisms of Cu regulation on HSC/HPC fate decisions, we performed experiments using the more de-tify and characterize this cell population. Cu is a cofactor of a key enzyme in the mitochondrial fined mouse model system. Using cell surface markers and mitochondrial dye Rho, we isolated HSCs and HPCs electron transport chain, cytochrome c oxidase (CCO). Reducing Cu content in cells has been shown to result in as separate populations from mouse bone marrow (27, 50) . When these two populations were cultured sepa-decreased activity of CCO and mitochondrial membrane potential in myogenic cells (5). To investigate whether rately in medium containing FBS and cytokines, they responded differently to Cu modulation. We performed Cu chelation decreases the mitochondrial membrane potential of cultured HPCs, we stained day 7 HPC cultures in vitro CFC assays to quantify the progenitor cell content in the day 7 and day 14 HPC and HSC cultures.
with JC-1, a cationic dye that indicates mitochondrial polarization by shifting its fluorescence emission from TEPA supplementation at 40 and 80 µM increased the total and erythroid CFC number in the HPC culture by green to red due to concentration-dependent formation of red fluorescent J-aggregates (47) . HPC cultured with two-to threefold compared to control cultures after 7 days of culture, and the relative increase was even more 40 and 80 µM TEPA contained a higher number of cells with low mitochondrial potential compared to control striking after 14 days of culture, although the overall CFC number was decreased from day 7. In contrast, the cultures. These cells may represent erythroid-biased progenitor cells. Currently, we do not know whether reduc-HSC cultures showed no difference in total CFC number due to TEPA or Cu supplementation after 7 days of cul-ing the mitochondrial membrane potential of these cells is responsible for the enhanced generation or mainte-ture. There were slight increases in total CFC numbers in HSC cultures supplemented with TEPA compared to nance of erythroid-biased progenitor cells in culture. Further studies are required to answer this question. controls and cultures supplemented with Cu for 14 days.
These in vitro CFC assay data suggest that Cu chela-Reducing cellular Cu content by TEPA may attenuate CCO activity, and this may in turn lead to a switch in tion has a positive effect on progenitor cell expansion or maintenance. We also assessed the in vivo repopulation metabolic flux towards glycolysis. Metabolic influences may be one mechanism by which HPCs regulate the potential of the cultured HPCs or HSCs by competitive repopulation assays. When the cultured cells competed choice between proliferation and differentiation (4). Mammalian cultures with impaired CCO maturation do with a fixed number of normal competitor BM cells, the HPCs cultured with 40 µM TEPA showed a twofold show a shift toward glycolysis. TEPA treatment can also reduce the reactive oxygen species (ROS) in some cell higher short-term erythroid repopulation potential compared to control culture cells. In contrast, the leukocyte types, including HPCs (45) . Reducing ROS level has been shown to be essential for the maintenance of HSCs and platelet lineage repopulation from cultured cells was decreased or unchanged by TEPA treatment. Cu addi-in bone marrow (24, 25, 54) , and control of ROS level is also essential for normal erythropoiesis (33) . Currently, tion had the opposite effect, and Cu reversed most effects of TEPA, indicating that intracellular Cu reduction we do not know if TEPA reduces the ROS level in HSC/ HPC in our culture system. Our results suggest it is very is largely responsible for TEPA's activities in our experiments. We transplanted cultures established from HSCs important to separate HSC activity from HPC activity and look for the repopulation potential in all blood lin-into lethally irradiated hosts in a competitive repopulation setting, and followed the contribution of cultured eages when testing the effects of changing Cu or ROS levels on HSCs and HPCs. cells to the peripheral blood of hosts periodically over a time frame up to 5 months posttransplantation. At 4 There are several mechanisms that can possibly ex-
